The hidden tax for those living outside Australian capital cities: 'A big strain'
Phil Leahy, from Port Douglas in Queensland's far north, was diagnosed with p16-positive oropharyngeal squamous cell carcinoma (OPSCC) earlier this year. It's a type of throat cancer that typically starts in the tonsils or base of the tongue and is commonly linked to the human papillomavirus (HPV).
The Queenslander was forced to leave his home and relocate to Brisbane to embark on an eight-week treatment plan that involves both radiation and chemotherapy. Phil founded his own business MedCart five years ago — a marketplace for medical, healthcare and pharmacy supplies — but was forced to take a major step back when he received his diagnosis.
His wife Annabel has taken over the reins from Phil as CEO while he's out of action, and, since falling ill, has also become the primary caretaker of the home.
Speaking to Yahoo News, Phil said that because their property is located within a rainforest, it requires regular maintenance, meaning Annabel isn't able to join him in Brisbane for treatment. He said between the cost of travelling back and forth, paying for everyday expenses — including food and transport — and the emotional toll of being separated from your partner, Australians living regionally face a much tougher challenge when it comes to accessing life-saving healthcare.
"Because Cairns doesn't offer dual treatment of chemo and radiation, I was forced to go to Brisbane," he said. "So in Far North Queensland, we're at a disadvantage there. And then you've got to think about all those extra costs of going interstate.
"There's the accommodation challenge. We were lucky to get an Airbnb that was quite cheap — I think it was $70 a night. But it can be anywhere from $200 a night to $335 or $400 a night for a 49-night stay. My wife is acting as CEO, she's got to manage the house and also the business without me there, so it's a big strain."
Phil said he initially opted for private care, thinking it would offer better flexibility and access. But he was surprised to learn that public hospital admission could have covered nearly all his treatment and support, something he only discovered after experiencing substantial out-of-pocket expenses. "I'm 60 years old, and I've been paying for private healthcare from the age of 18 — and I've been thinking twice about that now, if I could roll that back — it's very expensive."
Australia records highest rates of 'aggressive' cancer in the world
Risky activity Gen Z admit they love despite dire warning
Aussie family's remarkable bravery after baby girl's tragic diagnosis
With private health insurance in Australia, patients can choose their own hospital and specialist and may avoid long public waitlists. But many costs still aren't fully covered. As an outpatient staying nearby during treatment, Phil had to cover expenses like accommodation, meals, transport, and medications out of pocket, despite having paid for private health insurance for decades.
In contrast, the public healthcare system offers broader coverage if you're admitted as a public patient in a public hospital. Under Medicare, most hospital-based treatments — including accommodation, chemotherapy, radiation, and medications — are fully covered.
Phil later realised that had he gone through the public system and been admitted to a hospital, the majority of his expenses may have been taken care of. He believes many regional Australians aren't fully informed about how public and private care differ in practice, especially when it comes to serious illnesses like cancer.
According to data from the Australian Institute of Health and Welfare (AIHW), people living in rural and remote areas have higher rates of hospitalisations, deaths, and injury compared to those in major cities. These Australians often need to travel long distances or relocate to access health services or receive specialised treatment.
Phil's now calling for clearer guidance, better support systems, and improved access to life-saving treatment for those living outside metropolitan areas. "I'm meant to be at the end of treatment — they said after seven to 10 days, things should start to get better. But at the moment, they're getting worse. So I'm hoping I don't have to go back, but I might have to," Phil said.
"[People should] have a good think about whether they want to declare that they're going private. They might want to just go with public and get everything covered.
"I'll tell you that the doctors and nurses going down the private road were fantastic, and I wouldn't change that. But I didn't know what the other side was like either."
A fundraiser to assist Phil and his family with costs has been established and can be viewed here.
Do you have a story tip? Email: newsroomau@yahoonews.com.
You can also follow us on Facebook, Instagram, TikTok, Twitter and YouTube.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Forbes
2 hours ago
- Forbes
Cannabis And Psychedelics Seen As Effective For Eating Disorders, Study Finds
Anorexia Nervosa - Common Medical Marijuana Conditions for Qualifying Patients - use of the whole, ... More unprocessed marijuana plant or its basic extracts to treat symptoms of illness and other conditions. A new study has found that cannabis and psychedelics are perceived to be the most effective drugs that help alleviate eating disorder symptoms. A group of researchers from the University of Sydney has conducted a survey on over 6,000 people suffering from eight eating disorders, such as bulimia, anorexia, and binge-eating disorder, and found that most of them rely on cannabis and psychedelics to help alleviate their symptoms. Published on JAMA Network Open-Psychiatry this week, the study tried to understand which prescription and nonprescription drugs are used by people with eating disorders, and how they are associated with symptoms. To do so, participants, diagnosed with eating disorders and mainly from English-speaking countries, completed an online survey on recent prescribed and nonprescribed drug use, as well as perceived benefits and harms. Initially, 7,648 respondents were recruited; 6,612 completed demographics, and 5,123 finished the survey. The findings of the survey showed that overall, the best-rated drugs for eating disorder symptoms among respondents were psilocybin, cannabis, and lysergic acid diethylamide. For example, for respondents with anorexia, cannabis received the highest rating. When asked to identify their drug of choice for self-medicating eating disorder symptoms, the most popular drug among respondents was cannabis, but when normalized by number of users, fluoxetine, an antidepressant, ranked highest. Among 6,136 respondents, prescription psychotropics were rated highest for mental health. Psilocybin, LSD, and cannabis also received strong ratings. 'A striking outcome was the favorable self-reported ratings of psychedelics and cannabis for alleviating ED symptoms, eclipsing the ratings of commonly prescribed psychotropics,' the study reads. Can Cannabis Help Alleviate Eating Disorder Symptoms? The study also highlighted that daily cannabis users reported perceived benefits for their eating disorder symptoms. Researchers said that 'there is scant research around the use of cannabinoids in individuals with eating disorders apart from small trials supporting the efficacy of dronabinol, which is synthetic tetrahydrocannabinol, in those with anorexia nervosa.' They also added that cannabis may benefit people with restrictive and food-aversive eating disorders, like anorexia nervosa and avoidant/restrictive food intake disorder, 'by increasing the hedonic value of food.' This is in line with previous studies on the effects of cannabis on appetite. A study published last year showed that mediobasal hypothalamus (MBH), a region in the brain that regulates various physiological processes, controls increased appetite following cannabis use. In contrast, cannabis received poor ratings from people with bulimia and binge-eating disorder, likely because its appetite-stimulating effects can trigger or worsen binge-and-purge behaviors, thereby intensifying the symptoms of the eating disorder. Psilocybin and LSD were consistently rated highly across all diagnostic groups for their ability to improve eating disorder symptoms, enhance overall mental health, and be well tolerated. However, the study has several limitations. The survey primarily included participants from high-income, English-speaking countries with internet access. It may have also attracted people with eating disorders who are more inclined toward new ways to treat their eating disorder symptoms or have positive attitudes or prior positive experiences with drugs. Furthermore, diagnoses were based on self-report rather than formal clinical assessment, and comorbid conditions were not evaluated. Additionally, recall bias may have influenced participants' reports of drug use and symptoms. Therefore, because some findings are based on small sample sizes within specific diagnostic related to eating disorders and drug-use groups, the researchers highlighted that this study's results 'should be interpreted as exploratory rather than definitive.'
Yahoo
4 hours ago
- Yahoo
Tackling dementia: New approach urged
Urgent action is needed to fight the 'darkness' of dementia, as the deadly condition threatens to affect 850,000 Australians by 2058, a leading brain researcher has said. Dementia is estimated to cost Australia's economy $18bn each year, a figure that will more than double to $37bn in 25 years. But Professor Henry Brodaty spoke to the National Press Club on Wednesday about the need for a new approach to tackling brain health. He said tackling the syndrome would increase productivity in Australia, and delaying the effects of it would allow people to work longer, especially as the workforce ages. A new approach was needed with increased investment to become a world leader in preventing or delaying dementia onset, he said. 'Think about the slip, slop, slap for skin health,' he said. 'We need the slip, slop, slap of brain health, now. 'Funding for dementia has lagged behind cancer and heart disease, even though it contributes more to disease burden. 'Research is critical to find the best ways to provide services efficiently.' He said dementia develops in Aboriginal Australians and Torres Strait Islanders at 2-5 times the rate of the rest of the population, and suggested steps to counter this. 'Better care before, during and after pregnancy, and in early childhood, and particularly more education, could make a difference to this,' he said. Professor Brodaty said personalised coaching programs improved brain cognition, and increased people's fitness — pushing back the onset of dementia by a year or more. He said this could save Australia billions. 'Imagine what the return on investment would be if Australia did this?' he asked. 'Improving fitness, not only would improve cognition, it would improve fitness, physical, mental and social health.' But Professor Brodaty said Australia's National Dementia Action Plan has only $166m in funding, 'too little for what Australia needs'. 'I sympathise with the government, because there's always competing priorities and there's always other things that can be funded,' he said. 'But, when it makes sense economically, as well as personally to people, then why not do it?'
Yahoo
6 hours ago
- Yahoo
Prestige Consumer Healthcare Inc. (PBH) Reinvents Retail Strategy for the Digital Age
We recently published Prestige Consumer Healthcare Inc. stands first on our list and is accelerating digital shift and boosting retail speed. Prestige Consumer Healthcare Inc. (NYSE:PBH) tops the list for being the most undervalued stocks. It is a leading marketer of over-the-counter (OTC) healthcare products, offering a wide range of personal wellness brands like Monistat, Summer's Eve, Dramamine, Clear Eyes, and DenTek. Headquartered in Tarrytown, New York, the company operates across the U.S., Canada, Australia, and select international markets. In 2025, a major development will be Prestige Consumer Healthcare Inc. (NYSE:PBH)'s digital transformation. By centralizing content management through platforms like Salsify, the company can now update product descriptions, images, and health information across retail partners like Walmart and Target within hours instead of weeks. This has improved product accuracy, boosted e-commerce visibility, and allowed the company to respond quickly to trends and regulations. 15 States with the Best Healthcare in the US The company's digital strategy also focuses on enhancing consumer engagement with lifestyle imagery and user-generated content, helping build stronger brand connections. The digital upgrade has made the corporation a more agile, tech-forward healthcare company ready to meet the growing demand for online health solutions. Additionally, the business remains committed to quality and consumer safety. The call center fields over 75,000 consumer inquiries annually, which helps inform product innovation. Rigorous testing, compliance checks, and third-party audits ensure high standards across its supply chain. By investing in digital tools and maintaining strong retailer relationships, Prestige Consumer Healthcare Inc. (NYSE:PBH) continues to build consumer trust and loyalty while leading in the evolving OTC healthcare market. While we acknowledge the potential of PBH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. Sign in to access your portfolio